Report Categories
View AllRecent Articles
View All
Greenbrier GBX navigates challenging quarter with stock resilience despite 435 EPS miss and 86 revenue decline
Why Venture VG deserves a deeper look right now Smart Money Outflows 20260508
Is Qiagen QGEN stock considered a safe play 068 20260418
ACRE Ares CRE beats Q1 2026 earnings estimates by 176 shares rise 178
Deepa Jewellers and Cotec Healthcare Secure SEBI Approval for Initial Public Offerings
Qualcomms Recent Stock Rally Signals Growing Investor Confidence in AI Device Expansion
Europe Faces Strategic Vulnerability as US Dominance in Satellites and AI Grows Telecom CEO Warns
JapanChina Trade Chiefs Hold First FacetoFace Chat at APEC Since Fisheries Dispute
Treasury Yield Surge Challenges RiskFree Notion Opens Opportunities in Intermediates and High Yield
Oil Prices Post Weekly Decline as USIran Talks Show Potential Progress
First Commonwealth Financial Corporation FCF Q1 2026 Earnings EPS Misses Estimates Despite Stable Operations
APGE Q1 2026 Earnings Apogee Therapeutics Narrows Loss Per Share Stock Slips Slightly
VLTO Q1 2026 Earnings EPS Beat Drives Positive Stock Reaction
ULCC Q1 2026 Earnings WiderThanExpected Loss Narrows Shares Surge 7
NB Q1 2026 Earnings Surprise EPS Beat Amid Development Stage
Westport Fuel Systems WPRT Holds Steady Near Support Amid Modest Decline
Kimbell Royalty Partners KRP Edges Lower Amid Modest Trading Support and Resistance in Focus
Elutia Inc ELUT Slips 333 as Stock Tests Key Support Levels
Aytu BioPharma AYTU Holds Near Support Amid LowVolume Trading
External Links
Venture Capital Targets Boring Businesses with Thin Margins Using AI and Deal Flow
AVGO Q1 2026 Earnings EPS Miss and Tepid Stock Response Amid Mixed Signals
JBT Marel Corporation JBTM Gains 19 as Stock Tests Key Resistance at 141
Silvercorp Metals SVM Slips 327 as Selling Pressure Intensifies
NetScout Systems NTCT Edges Higher as Stock Approaches Key Resistance Level
Silicon Valley Acquisition Corp Warrants SVAQW Holds Steady Amid Consolidation
AppFolio Edges Higher as Shares Test Key Technical Levels
Monopar Therapeutics MNPR Surges 3 as Biotech Momentum Builds Tests Key Resistance
Nu Skin Edges Lower as Shares Test Key Support Level